 Insulin Infusion Systems
"Insulin Infusion Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.
| Descriptor ID |
D007332
|
| MeSH Number(s) |
E02.319.300.508 E07.505.508 E07.858.082.505.508
|
| Concept/Terms |
Insulin Infusion Systems- Insulin Infusion Systems
- Infusion System, Insulin
- Infusion Systems, Insulin
- Insulin Infusion System
- System, Insulin Infusion
- Systems, Insulin Infusion
Implantable Programmable Insulin Pump- Implantable Programmable Insulin Pump
- Programmable Implantable Insulin Pump
- Pump, Programmable Implantable Insulin
- Insulin Pump, Programmable Implantable
beta Cell, Artificial- beta Cell, Artificial
- Artificial beta Cell
- Artificial beta Cells
- Cell, Artificial beta
- Cells, Artificial beta
- beta Cells, Artificial
|
Below are MeSH descriptors whose meaning is more general than "Insulin Infusion Systems".
Below are MeSH descriptors whose meaning is more specific than "Insulin Infusion Systems".
This graph shows the total number of publications written about "Insulin Infusion Systems" by people in this website by year, and whether "Insulin Infusion Systems" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 | | 2003 | 0 | 1 | 1 | | 2004 | 2 | 0 | 2 | | 2005 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 6 | 2 | 8 | | 2010 | 2 | 2 | 4 | | 2011 | 1 | 0 | 1 | | 2012 | 2 | 2 | 4 | | 2013 | 4 | 2 | 6 | | 2014 | 3 | 3 | 6 | | 2015 | 5 | 4 | 9 | | 2016 | 7 | 3 | 10 | | 2017 | 8 | 9 | 17 | | 2018 | 13 | 7 | 20 | | 2019 | 8 | 8 | 16 | | 2020 | 15 | 11 | 26 | | 2021 | 5 | 13 | 18 | | 2022 | 3 | 19 | 22 | | 2023 | 3 | 9 | 12 | | 2024 | 24 | 8 | 32 | | 2025 | 31 | 2 | 33 | | 2026 | 9 | 4 | 13 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin Infusion Systems" by people in Profiles.
-
Montaser E, Bhasin K, Kruger D, Akturk HK, Ahmann A, Snell-Bergeon JK, Shah VN. Glycaemic Changes After Semaglutide Discontinuation in Adults With Type 1 Diabetes Using Automated Insulin Delivery: Analysis of the ADJUST-T1D Extension Study. Diabetes Obes Metab. 2026 Nov; 28(11):10736-10742.
-
Davis GM, Forlenza GP, Gehr B, Pemberton J, Penfornis A, Do D, Huyett LM, Ly TT. Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes. Diabetes Res Clin Pract. 2026 Sep; 239:113450.
-
Martens TW, Patel BV, Wang SM, Messer LH, Pinsker JE, Malone DC, Polin MR, Brixner DI, Isaacs D, Ebekozien O. Impact of Automated Insulin Delivery on Type 2 Diabetes Measures. Am J Manag Care. 2026 Jul 01; 32(7):e222-e227.
-
Al Rawashdh N, Patel BV, Wang SM, Zur RM, Anaya P, Kahn EB, Pinsker JE, Sasson-Katchalski R, Trahan AC, Messer LH, Assadi K, Kudva YC, Beck RW. Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients With Type 2 Diabetes in the United States. Diabetes Obes Metab. 2026 07; 28(7):6280-6290.
-
Karakus KE, Akturk HK, Kruger D, Ahmann A, Bharvaga A, Langel CR, Ackeifi CA, Rosen J, Pyle L, Snell-Bergeon JK, Shah VN. Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis. Diabetes Care. 2026 May 01; 49(5):718-723.
-
Akturk HK, Nally LM, Lal RA, Warren ML, Demeterco-Berggren C, Forlenza GP, Reed JC, Shulman DI, Kipnes MS, Bode BW, Dewan AK, Liljenquist DR, Kudva YC, Niu F, Yovanovich C, Shin JJ, Cordero TL, McVean JJF, Vigersky RA, Bergenstal RM. Safety and Effectiveness of MiniMedTM 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes. Diabetes Technol Ther. 2026 Nov; 28(11):1181-1192.
-
Seget S, Rusak E, Pelicand J, Fry M, Sheanon N, Schierloh U, Xatzipsalti M, Malinici E, Tinti D, Neylon O, Bazdarska Y, Cobry E, Hauser E. Automated insulin delivery use in children and adolescents with type 1 diabetes across the world. Diabetes Res Clin Pract. 2026 Jun; 236:113253.
-
Moscoso-Vasquez M, Ekhlaspour L, Brown SA, DeBoer MD, Berget C, Cobry EC, Wadwa RP, Capodanno G, Cengiz E, Wong JC, Pryor EC, Villa-Tamayo MF, El Fathi A, Holmes V, Davis Prince S, Escobar E, Towers L, Hosseininpour Y, Narayan A, Koravi CLK, Nguyen T, Fulkerson D, Barnett CL, Oliveri MC, Breton MD, Forlenza GP. Safety and Feasibility of a Fully Automated Insulin Delivery System: FCL@Home, a Multicenter Randomized Clinical Trial in Individuals With Type 1 Diabetes. Diabetes Care. 2026 Mar 01; 49(3):401-409.
-
Nally LM, Sherr JL, Garg SK, Marks BE, Laffel LM, Pihoker C, Accacha SD, Thrasher JR, Abuzzahab MJ, Reed JH, Ekhlaspour L, Belapurkar S, Shulman DI, Sunil B, MacLeish SA, Latif K, Forlenza GP, Castorino K, Lal RA, Bode BW, Broyles FE, Carlson AL, Nwosu BU, Shin J, Ma H, Salbato A, Cordero TL, Treminio Y, McVean JJ, Rhinehart AS, Vigersky RA. Safety and Glycemic Outcomes of the MiniMed 780G System with a Disposable All-in-One Sensor. Diabetes Technol Ther. 2026 Feb; 28(2):109-120.
-
Shah VN, Choudhary P, Halperin I, Rabbone I, Zaharieva DP, Messer L. Rethinking control-IQ+ technology: Simple strategies for easy optimization. Diabetes Obes Metab. 2026 05; 28(5):3502-3514.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|